Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Venetoclax Combined With Azacitidine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05448599
What this trial is testing

A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Mabwell (Shanghai) Bioscience Co., Ltd. 120
Large-scale testing (Phase 3)Study completedNCT05654194
What this trial is testing

Azacitidine Combined With Venetoclax and ATRA in Newly Diagnosed AML

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT07486479
What this trial is testing

Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML

Who this might be right for
Acute Myeloid Leukemia (AML)
The First Affiliated Hospital of Soochow University 204
Testing effectiveness (Phase 2)Looking for participantsNCT06504459
What this trial is testing

Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML

Who this might be right for
Acute Monocytic LeukemiaAcute Myeloid Leukemia
OHSU Knight Cancer Institute 40
Large-scale testing (Phase 3)Active Not RecruitingNCT02993523
What this trial is testing

Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 443
Testing effectiveness (Phase 2)Active Not RecruitingNCT05520567
What this trial is testing

Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)FLT3-mutated Acute Myeloid Leukemia
Astellas Pharma Global Development, Inc. 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07505160
What this trial is testing

Efficacy and Safety of Lisafotoclax Plus Decitabine and Homoharringtonine in Venetoclax/Azacitidine Pretreated AML Patients

Who this might be right for
Acute Myeloid Leukemia (AML)
Second Affiliated Hospital, Zhejiang University, School of Medicine 35
Large-scale testing (Phase 3)Looking for participantsNCT04256317
What this trial is testing

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid LeukemiaMyelodysplastic Syndrome/Neoplasm+1 more
Taiho Oncology, Inc. 316
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07507825
What this trial is testing

Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)

Who this might be right for
Acute Myeloid Leukemia (AML)
First People's Hospital of Hangzhou 61
Early research (Phase 1)Looking for participantsNCT07177079
What this trial is testing

High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Kittika Poonsombudlert 30
Testing effectiveness (Phase 2)Looking for participantsNCT07012447
What this trial is testing

Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations

Who this might be right for
Early T Acute Lymphoblastic LeukemiaT-Acute Lymphoblastic LeukemiaMixed Phenotype Acute Leukemia, T/Myeloid, Nos
yuejun Liu 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06598384
What this trial is testing

VA as Maintenance Therapy Post Allo-HSCT in MDS and AML

Who this might be right for
Acute Myeloid Leukemia
Navy General Hospital, Beijing 40
Early research (Phase 1)Not Yet RecruitingNCT07392814
What this trial is testing

Study With Tocilizumab in Combination With Venetoclax and Azacitidine Chemotherapy in Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia Acute Myeloid - AML
Nantes University Hospital 12
Large-scale testing (Phase 3)Looking for participantsNCT07581002
What this trial is testing

Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
AbbVie 660
Early research (Phase 1)Study completedNCT02942290
What this trial is testing

A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes (MDS)
AbbVie 134
Testing effectiveness (Phase 2)Looking for participantsNCT06783790
What this trial is testing

Avapritinib Combined With Azacitidine and Venetoclax in the Treatment of Relapsed AML After Allo-HSCT

Who this might be right for
AML (Acute Myelogenous Leukemia)
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Looking for participantsNCT05431257
What this trial is testing

Azacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML Profiling

Who this might be right for
Acute Myeloid Leukemia
Rigshospitalet, Denmark 117
Early research (Phase 1)Not Yet RecruitingNCT07828535
What this trial is testing

Liposomal Mitoxantrone Plus Azacitidine and Venetoclax in Newly Diagnosed Elderly or Unfit AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Institute of Hematology & Blood Diseases Hospital, China 30
Early research (Phase 1)Ended earlyNCT04964505
What this trial is testing

Uproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Brian Jonas 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT05379166
What this trial is testing

Venetoclax and Azacitidine for Treatment of Therapy Related or Secondary Myelodysplastic Syndrome

Who this might be right for
Secondary Myelodysplastic SyndromeTherapy-Related Myelodysplastic Syndrome
Uma Borate 33
Next Page